Head to head

Harmony XL Pro vs Stellar M22 (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: No new-price range is on file for either Harmony XL Pro or Stellar M22. Request current quotes to compare purchase costs.
Practice fit: Harmony XL Pro: multi-app platform. Stellar M22: IPL multi-app platform. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

Multi-app platform

View full device profile →

Device B

IPL multi-app platform

View full device profile →

Price comparison

Price comparison: Alma Harmony XL Pro vs Lumenis Stellar M22
Attribute	Alma Harmony XL Pro	Lumenis Stellar M22
New price range	Not published	Not published
Used price reference	$55,975 (single dealer asking price)Reported source: Used listing · Oct 2, 2026	$55k–$85kSource not documented
Payback calculator	View ROI calculator	View ROI calculator
Next step

New price range

Alma Harmony XL Pro: Not published
Lumenis Stellar M22: Not published

Used price reference

Alma Harmony XL Pro: $55,975 (single dealer asking price)Reported source: Used listing · Oct 2, 2026
Lumenis Stellar M22: $55k–$85kSource not documented

Payback calculator

Alma Harmony XL Pro: View ROI calculator
Lumenis Stellar M22: View ROI calculator

Next step

Alma Harmony XL Pro

Lumenis Stellar M22

Supplies & running costs

Supplies & running costs: Alma Harmony XL Pro vs Lumenis Stellar M22
Attribute	Alma Harmony XL Pro	Lumenis Stellar M22
Supplies & restrictions	Supply pricing is not documented with a dated source yet. Request an itemized supply quote. View running-cost details	Supply pricing is not documented with a dated source yet. Request an itemized supply quote. View running-cost details

Supplies & restrictions

Alma Harmony XL Pro: Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
View running-cost details
Lumenis Stellar M22: Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
View running-cost details

FDA status & indications

FDA status & indications: Alma Harmony XL Pro vs Lumenis Stellar M22
Attribute	Alma Harmony XL Pro	Lumenis Stellar M22
FDA status & indication	FDA record cited — see scopeK072564, K181298, K230308, K233024, K243044 Record scope: The cited records cover particular Harmony platforms and handpieces. K181298 concerns the Harmony XL platform with the Dye VL handpiece (500–600 nm), including its specified pigmented and vascular lesion indications and skin types I–V. Later Alma Harmony filings should not be read as blanket clearance of every Harmony XL Pro configuration. Match the console and handpiece to the applicable labeling. Read FDA indication wording “[…] 540-950 nm VL/PL, VP, and SSR Module AFT Handpieces: The Advanced Fluorescence Technology (AFT) 540-950 nm VL/PL, VP, and SSR Module handpieces (with and without contact-cooling) are indicated for: The treatment of moderate inflammatory acne vulgaris. The treatment of benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles), lentigines, nevi, melasma, and café-au-lait macules. The treatment of cutaneous lesions including warts, scars and striae. The treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. The removal of unwanted hair to effect stable long-term or permanent hair reduction. Use on all skin types (Fitzpatrick I-VI). 570-950 nm SR Module AFT Handpiece: The Advanced Fluorescence Technology (AFT) 570-950 nm SR Module handpiece (with and without contact-cooling) is indicated for: The treatment of moderate inflammatory acne vulgaris. The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma and ephelides (freckles). The treatment of face and body vascular and pigmented lesions. The treatment of cutaneous lesions, including scars and striae. The treatment of benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, melasma, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. The removal of unwanted hair to effect stable long-term or permanent hair reduction. Use on all skin types (Fitzpatrick I-VI).”	FDA record cited — see scopeK193500, K250809, De Novo: DEN200028 Record scope: 510(k): K193500 and K250809. De Novo: DEN200028 (dry eye) is a separate authorization. Checked 4 Sep 2026. Read FDA indication wording “The subject Stellar M22 has connection capability with the following available treatment handpieces, for multi-application treatment options. All handpieces are designed for aesthetic and dermatological skin procedure applications, as follows:  The Intense Pulsed Light (IPL) handpiece with a spectrum of 400-1200 nm (with 9 different filters) is indicated for: o Benign epidermal lesions, including dyschromia, hyperpigmentation, melasma, and ephelides (freckles) o Cutaneous lesions, including warts, scars and striae o Benign cutaneous vascular lesions, including port wine stains, hemoangiomas, facial, truncal and leg telangiectasias, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations o Removal of unwanted hair and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles o Mild to moderate inflammatory Acne (Acne vulgaris)  The Nd:YAG Laser handpiece with a wavelength of 1064 nm (Multi-Spot Nd:YAG) is indicated for: o The coagulation and hemostasis of vascular lesions and soft tissue, including the treatment and clearance of superficial and deep telangiectasias (venulectasias) and reticular veins (0.1-4.0 mm. diameter) of the leg o The removal of unwanted hair and to effect table long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles o The non-ablative treatment of facial wrinkles  ResurFX module and handpiece, with wavelength of 1565 nm, is indicated for: o Use in dermatological procedures requiring fractional skin resurfacing and0684 coagulation of soft tissue  The Q-Switched Nd:YAG Laser Handpiece with a wavelength of 1064 nm is indicated for: o Removal of dark tattoos o Treatment of pigmented lesions *Note Permanent hair reduction is defined as long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after completion of treatment regime.”

FDA status & indication

Alma Harmony XL Pro: FDA record cited — see scopeK072564, K181298, K230308, K233024, K243044
Record scope: The cited records cover particular Harmony platforms and handpieces. K181298 concerns the Harmony XL platform with the Dye VL handpiece (500–600 nm), including its specified pigmented and vascular lesion indications and skin types I–V. Later Alma Harmony filings should not be read as blanket clearance of every Harmony XL Pro configuration. Match the console and handpiece to the applicable labeling.
Read FDA indication wording
“[…] 540-950 nm VL/PL, VP, and SSR Module AFT Handpieces: The Advanced Fluorescence Technology (AFT) 540-950 nm VL/PL, VP, and SSR Module handpieces (with and without contact-cooling) are indicated for: The treatment of moderate inflammatory acne vulgaris. The treatment of benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasma, and ephelides (freckles), lentigines, nevi, melasma, and café-au-lait macules. The treatment of cutaneous lesions including warts, scars and striae. The treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. The removal of unwanted hair to effect stable long-term or permanent hair reduction. Use on all skin types (Fitzpatrick I-VI). 570-950 nm SR Module AFT Handpiece: The Advanced Fluorescence Technology (AFT) 570-950 nm SR Module handpiece (with and without contact-cooling) is indicated for: The treatment of moderate inflammatory acne vulgaris. The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma and ephelides (freckles). The treatment of face and body vascular and pigmented lesions. The treatment of cutaneous lesions, including scars and striae. The treatment of benign cutaneous vascular lesions, including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, melasma, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations. The removal of unwanted hair to effect stable long-term or permanent hair reduction. Use on all skin types (Fitzpatrick I-VI).”
Lumenis Stellar M22: FDA record cited — see scopeK193500, K250809, De Novo: DEN200028
Record scope: 510(k): K193500 and K250809. De Novo: DEN200028 (dry eye) is a separate authorization. Checked 4 Sep 2026.
Read FDA indication wording
“The subject Stellar M22 has connection capability with the following available treatment handpieces, for multi-application treatment options. All handpieces are designed for aesthetic and dermatological skin procedure applications, as follows:  The Intense Pulsed Light (IPL) handpiece with a spectrum of 400-1200 nm (with 9 different filters) is indicated for: o Benign epidermal lesions, including dyschromia, hyperpigmentation, melasma, and ephelides (freckles) o Cutaneous lesions, including warts, scars and striae o Benign cutaneous vascular lesions, including port wine stains, hemoangiomas, facial, truncal and leg telangiectasias, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, leg veins and venous malformations o Removal of unwanted hair and to effect stable long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles o Mild to moderate inflammatory Acne (Acne vulgaris)  The Nd:YAG Laser handpiece with a wavelength of 1064 nm (Multi-Spot Nd:YAG) is indicated for: o The coagulation and hemostasis of vascular lesions and soft tissue, including the treatment and clearance of superficial and deep telangiectasias (venulectasias) and reticular veins (0.1-4.0 mm. diameter) of the leg o The removal of unwanted hair and to effect table long term, or permanent* hair reduction in skin types I-V through selective targeting of melanin in hair follicles o The non-ablative treatment of facial wrinkles  ResurFX module and handpiece, with wavelength of 1565 nm, is indicated for: o Use in dermatological procedures requiring fractional skin resurfacing and0684 coagulation of soft tissue  The Q-Switched Nd:YAG Laser Handpiece with a wavelength of 1064 nm is indicated for: o Removal of dark tattoos o Treatment of pigmented lesions *Note Permanent hair reduction is defined as long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after completion of treatment regime.”

Which chains run each

Which chains run each: Alma Harmony XL Pro vs Lumenis Stellar M22
Attribute	Alma Harmony XL Pro	Lumenis Stellar M22
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

Alma Harmony XL Pro: 0 recorded pairings
Lumenis Stellar M22: 0 recorded pairings

Chains using it

Alma Harmony XL Pro: —
Lumenis Stellar M22: —

Approved reviews

Alma Harmony XL Pro: 0
Lumenis Stellar M22: 0

Specs and platform

Specs and platform: Alma Harmony XL Pro vs Lumenis Stellar M22
Attribute	Alma Harmony XL Pro	Lumenis Stellar M22
Manufacturer	Alma	Lumenis
Built by (OEM)	Alma Lasers Ltd.	Lumenis Be Ltd.
Category	Multi-app platform	IPL multi-app platform
Technology	AFT IPL + multiple laser modules (IPL)	Updated M22, larger IPL spot (IPL)
Launch year	2015	2019
Status	Current	Current
Manufacturing relationship evidence	No separate manufacturing-relationship record linked.	No separate manufacturing-relationship record linked.

Manufacturer

Alma Harmony XL Pro: Alma
Lumenis Stellar M22: Lumenis

Built by (OEM)

Alma Harmony XL Pro: Alma Lasers Ltd.
Lumenis Stellar M22: Lumenis Be Ltd.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Cutera Xeo

Multi-app platform

New-equipment price reference

$80k–$120k

Source not documented

Check the profile for configuration and price details.

Rohrer Aesthetics Spectrum

Multi-app platform

New-equipment price reference

$79,995 (Rohrer-advertised price)

Reported source: Manufacturer-provided · Oct 1, 2026

Check the profile for configuration and price details.

SharpLight OmniMax S4

IPL multi-app platform

New-equipment price reference

$60k–$90k

Source not documented

Check the profile for configuration and price details.

Venus Versa Pro

IPL multi-app platform

New-equipment price not yet documented.

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.